rubitecan
Term · Oncology and biomedicine · MLC-T-ONC-016597
A semisynthetic agent related to camptothecin with potent antitumor and antiviral properties. Rubitecan binds to and inhibits the enzyme topoisomerase I and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells; this agent also prevents repair of reversible single-strand DNA breaks.
| Identifier | MLC-T-ONC-016597 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | 9-NC |
| Synonyms | 9-nitro-CPT; 9-nitrocamptothecin; nitrocamptothecin |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016597",
"term": "rubitecan",
"field": "Oncology and biomedicine",
"definition": "A semisynthetic agent related to camptothecin with potent antitumor and antiviral properties. Rubitecan binds to and inhibits the enzyme topoisomerase I and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells; this agent also prevents repair of reversible single-strand DNA breaks.",
"abbreviation": "9-NC",
"synonyms": [
"9-nitro-CPT",
"9-nitrocamptothecin",
"nitrocamptothecin"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/rubitecan/"
}
Record 14,605 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.